X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
female (23) 23
oncology (20) 20
middle aged (16) 16
radiology, nuclear medicine & medical imaging (16) 16
radiotherapy (15) 15
adult (14) 14
cervical cancer (13) 13
hematology, oncology and palliative medicine (13) 13
radiology (13) 13
index medicus (12) 12
radiology and nuclear medicine (12) 12
aged (11) 11
cancer (11) 11
chemotherapy (10) 10
care and treatment (9) 9
uterine cervical neoplasms - pathology (9) 9
uterine cervical neoplasms - radiotherapy (9) 9
carcinoma (8) 8
radiation (8) 8
surgery (8) 8
neoplasms (7) 7
patients (7) 7
radiation-therapy (7) 7
carcinomas (6) 6
retrospective studies (6) 6
treatment outcome (6) 6
uterine cervical neoplasms - surgery (6) 6
article (5) 5
carcinoma, squamous cell - radiotherapy (5) 5
clinical trials (5) 5
lymph nodes (5) 5
lymphatic metastasis (5) 5
neoplasm staging (5) 5
carcinoma, squamous cell - drug therapy (4) 4
concurrent chemotherapy (4) 4
disease-free survival (4) 4
gynecologic-oncology-group (4) 4
irradiation (4) 4
prospective studies (4) 4
therapy (4) 4
uterine cervical neoplasms - diagnostic imaging (4) 4
uterine cervical neoplasms - drug therapy (4) 4
uterine cervical neoplasms - therapy (4) 4
aged, 80 and over (3) 3
brachytherapy (3) 3
brachytherapy - methods (3) 3
cancer patients (3) 3
chemoradiation (3) 3
cisplatin (3) 3
cisplatin - administration & dosage (3) 3
combined modality therapy - methods (3) 3
computerized tomography (3) 3
diseases (3) 3
endometrial neoplasms - radiotherapy (3) 3
gynecologic malignancies (3) 3
health aspects (3) 3
imrt (3) 3
lymph nodes - pathology (3) 3
lymph-nodes (3) 3
medical colleges (3) 3
medicine (3) 3
metastases (3) 3
nuclear medicine (3) 3
nuclear radiation (3) 3
obstetrics & gynecology (3) 3
pelvic radiation (3) 3
pelvis (3) 3
prognosis (3) 3
radiation doses (3) 3
radiation oncology - standards (3) 3
radiation therapy (3) 3
radiotherapy dosage (3) 3
radiotherapy, intensity-modulated - methods (3) 3
recommendations (3) 3
survival (3) 3
survival rate (3) 3
toxicity (3) 3
urogenital system diseases (3) 3
uterine cervix (3) 3
adenocarcinoma - drug therapy (2) 2
adenocarcinoma - radiotherapy (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
bladder (2) 2
brachytherapy - adverse effects (2) 2
carcinoma, adenosquamous - drug therapy (2) 2
carcinoma, adenosquamous - radiotherapy (2) 2
carcinoma, squamous cell - pathology (2) 2
carcinoma, squamous cell - secondary (2) 2
cervix (2) 2
cisplatin - adverse effects (2) 2
combined modality therapy (2) 2
combined modality therapy - adverse effects (2) 2
endometrial neoplasms - diagnostic imaging (2) 2
endometrial neoplasms - surgery (2) 2
extended-field (2) 2
failures (2) 2
follow-up studies (2) 2
gastrointestinal toxicity (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. e353 - e362
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 79, Issue 2, pp. 348 - 355
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 71, Issue 2, pp. 428 - 434
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 256 - 262
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 68, Issue 4, pp. 1081 - 1087
Purpose: The Radiation Therapy Oncolology Group (RTOG) 0116 trial was designed to test the ability of Amifostine to reduce the toxicity of combined... 
Radiology | Hematology, Oncology and Palliative Medicine | Extended-field radiotherapy | Toxicity | Chemoradiation | Cervical cancer | toxicity | SURVIVAL | GYNECOLOGIC-ONCOLOGY-GROUP | extended-field radiotherapy | PELVIC RADIATION | STAGE-IB | cervical cancer | RADIATION-THERAPY | AORTIC NODES | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | CONCURRENT CHEMOTHERAPY | RADIOTHERAPY | chemoradiation | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Carcinoma, Adenosquamous - drug therapy | Antineoplastic Agents - therapeutic use | Radiotherapy - adverse effects | Carcinoma, Squamous Cell - radiotherapy | Feasibility Studies | Radiation-Sensitizing Agents - therapeutic use | Antineoplastic Agents - adverse effects | Adult | Female | Adenocarcinoma - radiotherapy | Radiotherapy Dosage | Uterine Cervical Neoplasms - radiotherapy | Brachytherapy - methods | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Lymphatic Metastasis | Combined Modality Therapy - adverse effects | Adenocarcinoma - drug therapy | Radiation-Sensitizing Agents - adverse effects | Adenocarcinoma - secondary | Carcinoma, Adenosquamous - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Carcinoma, Adenosquamous - secondary | Radiotherapy - methods | Cisplatin - adverse effects | Carcinoma, Squamous Cell - secondary | Aged | Combined Modality Therapy - methods | Brachytherapy - adverse effects | Cisplatin | SURGERY | IRRADIATION | PATIENTS | LYMPH NODES | METASTASES | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | TOXICITY | LEUKOPENIA | BRACHYTHERAPY | CHEMOTHERAPY
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 70, Issue 1, pp. 118 - 125
Purpose To compare the treatment and outcomes of cervical cancer patients treated with concurrent chemoradiotherapy (CT-RT) in a multi-institutional trial or... 
Radiology | Hematology, Oncology and Palliative Medicine | Treatment tolerance | Compliance | Concurrent chemoradiotherapy | Outcome | Cervical cancer | PELVIC RADIATION | cervical cancer | CHEMOTHERAPY | RADIATION-THERAPY | CISPLATIN | ONCOLOGY | concurrent chemoradiotherapy | compliance | CHEMORADIATION | RADIOTHERAPY | treatment tolerance | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | outcome | Multivariate Analysis | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma, Adenosquamous - drug therapy | Carcinoma, Squamous Cell - radiotherapy | Cisplatin - administration & dosage | Neutropenia - etiology | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Fluorouracil - adverse effects | Carcinoma, Adenosquamous - mortality | Female | Retrospective Studies | Uterine Cervical Neoplasms - mortality | Adenocarcinoma - radiotherapy | Uterine Cervical Neoplasms - radiotherapy | Proportional Hazards Models | Survival Rate | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Combined Modality Therapy - adverse effects | Adenocarcinoma - drug therapy | Carcinoma, Adenosquamous - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cisplatin - adverse effects | Combined Modality Therapy - methods | Leukopenia - etiology | Adenocarcinoma - mortality | Cancer patients | Care and treatment | Patient outcomes | Analysis | Clinical trials | Cancer | PATIENTS | URACILS | NEOPLASMS | LYMPH NODES | TOLERANCE | RADIATION DOSES | TOXICITY | COMPLIANCE | MULTIVARIATE ANALYSIS | RADIOLOGY AND NUCLEAR MEDICINE | COMBINED THERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 2012 - 2017
Objectives Carcinoma of unknown primary (CUP) in the abdomen and pelvis is a heterogeneous group of cancers with no standard treatment. Considered by many to... 
Radiology | Hematology, Oncology and Palliative Medicine | Lymph node metastasis | Intensity-modulated radiation therapy | Carcinoma of unknown primary | Conformal radiation therapy | Chemoradiation | GASTROINTESTINAL TOXICITY | SURVIVAL | NODES | PRIMARY SITE | ADENOCARCINOMA | METASTASES | CHEMOTHERAPY | ORIGIN | PRIMARY-CANCER | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Humans | Middle Aged | Pelvic Neoplasms - mortality | Soft Tissue Neoplasms - drug therapy | Male | Palliative Care | Pelvic Neoplasms - radiotherapy | Pelvic Neoplasms - drug therapy | Adult | Female | Pelvic Neoplasms - pathology | Abdominal Neoplasms - radiotherapy | Neoplasms, Unknown Primary - drug therapy | Soft Tissue Neoplasms - mortality | Abdominal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Neoplasms, Unknown Primary - radiotherapy | Survival Rate | Lymphatic Metastasis | Neoplasms, Unknown Primary - mortality | Disease-Free Survival | Soft Tissue Neoplasms - radiotherapy | Abdominal Neoplasms - mortality | Soft Tissue Neoplasms - pathology | Abdominal Neoplasms - pathology | Aged | Neoplasms, Unknown Primary - pathology | Radiotherapy, Conformal - methods | Antimitotic agents | Care and treatment | Chemotherapy | Carcinoma | Nuclear radiation | Radiation | Radiotherapy | Antineoplastic agents | Cancer | Abdomen | Index Medicus | SURGERY | PATIENTS | ABDOMEN | LYMPH NODES | MEDICAL RECORDS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | PELVIS | TOXICITY | RADIOTHERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 5, pp. 1331 - 1336
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2008, Volume 71, Issue 1, pp. 226 - 236
Purpose The purpose of this study was to investigate early gene expression changes after chemoradiation in a human solid tumor, allowing identification of... 
Radiology | Hematology, Oncology and Palliative Medicine | Radiation response | Prognosis | DNA damage | Radiation | Gene expression | Microarray | Cervical cancer | IMUP-2 GENES | DNA MICROARRAY | TUMOR RESPONSE | cervical cancer | prognosis | radiation response | RADICAL RADIOTHERAPY | FALSE DISCOVERY RATE | microarray | IN-VITRO | ONCOLOGY | radiation | HYPOXIA-INDUCIBLE FACTOR-1-ALPHA | CDNA MICROARRAY ANALYSIS | CONCURRENT CHEMOTHERAPY | IONIZING-RADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | gene expression | Prospective Studies | Uterine Cervical Neoplasms - radiotherapy | Follow-Up Studies | Gene Expression - drug effects | Oligonucleotide Array Sequence Analysis | Gene Expression - genetics | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Gene Expression Profiling - methods | Uterine Cervical Neoplasms - drug therapy | Uterine Cervical Neoplasms - pathology | Signal Transduction - genetics | DNA Repair - genetics | Carcinoma, Squamous Cell - radiotherapy | Uterine Cervical Neoplasms - genetics | Gene Expression - radiation effects | Pilot Projects | Carcinoma, Squamous Cell - drug therapy | Polymerase Chain Reaction | Adult | Female | Neoplasm Staging | Squamous cell carcinoma | Care and treatment | Patient outcomes | Genetic research | Genetic aspects | Cancer | INSULIN | APOPTOSIS | PATIENTS | INTERFERON | GENES | CARCINOMAS | DNA REPAIR | RADIOLOGY AND NUCLEAR MEDICINE | BIOLOGICAL RADIATION EFFECTS | RADIOTHERAPY | DNA DAMAGES
Journal Article